The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

HCA Holdings Inc

NYSE: HCA
Last

(U.S.) $67.30

Today's change+0.80 +1.20%
Updated February 10 4:02 PM EST. Delayed by at least 15 minutes.
 

HCA Holdings Inc

NYSE: HCA
Last

(U.S.) $67.30

Today's change+0.80 +1.20%
Updated February 10 4:02 PM EST. Delayed by at least 15 minutes.

HCA Holdings Inc crosses above 50-day moving average

HCA Holdings Inc closed up Wednesday by (U.S.)$0.80 or 1.20% to (U.S.)$67.30 and crossing above its 50-day moving average. Shares have lost 4.13% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 8.00% during the last year.

Key company metrics

  • Open(U.S.) $66.77
  • Previous close(U.S.) $66.50
  • High(U.S.) $68.51
  • Low(U.S.) $66.71
  • Bid / Ask(U.S.) $67.00 / (U.S.) $71.88
  • YTD % change-0.49%
  • Volume2,468,512
  • Average volume (10-day)4,568,492
  • Average volume (1-month)4,269,820
  • Average volume (3-month)4,431,491
  • 52-week range(U.S.) $43.91 to (U.S.) $95.49
  • Beta1.06
  • Trailing P/E13.49×
  • P/E 1 year forward10.63×
  • Forward PEG1.06×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.99
Updated February 10 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.79%

Based on its net profit margin of 6.79%, HCA Holdings Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.79%Sector:HealthcareIndustry:Healthcare Facilities

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue10,2499,8569,8979,676
Total other revenue--------
Total revenue10,2499,8569,8979,676
Gross profit8,5638,2128,2278,038
Total cost of revenue1,6861,6441,6701,638
Total operating expense8,7888,6098,4938,207
Selling / general / administrative6,4416,4156,2476,115
Research & development--------
Depreciation / amortization480482469473
Interest expense (income), net operating--------
Unusual expense (income)18277125--
Other operating expenses, total-1-9-18-19
Operating income1,4611,2471,4041,469
Interest income (expense), net non-operating-410-411-425-419
Gain (loss) on sale of assets-7-2-59
Other--------
Income before tax1,0528439841,078
Income after tax738573665720
Income tax, total314270319358
Net income582449507591
Total adjustments to net income--------
Net income before extra. items582449507591
Minority interest-156-124-158-129
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items582449507591
Inc. avail. to common incl. extra. items582449507591
Diluted net income582449507591
Dilution adjustment--------
Diluted weighted average shares416426429435
Diluted EPS excluding extraordinary itemsvalue per share1.401.051.181.36
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.721.181.391.34